Aktis Oncology, Inc. Common stock (AKTS) — Free Cash Flow Generation Index

Latest as of December 2024: 0.81x

Aktis Oncology, Inc. Common stock (AKTS) has a Free Cash Flow Generation Index of 0.81x as of December 2024. Free cash flow of $11.90 Million represents 1% of operating cash flow ($14.76 Million). Explore Aktis Oncology, Inc. Common stock (AKTS) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.81x
Free Cash Flow / Operating CF

Free Cash Flow

$11.90 Million
USD

Operating Cash Flow

$14.76 Million
USD

Capital Expenditures

$2.86 Million
USD

Aktis Oncology, Inc. Common stock Free Cash Flow Generation Index (2024–2024)

Historical FCF Generation Index trend for Aktis Oncology, Inc. Common stock across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Aktis Oncology, Inc. Common stock.

Annual Free Cash Flow Generation for Aktis Oncology, Inc. Common stock (2024–2024)

Year-by-year Free Cash Flow Generation Index for Aktis Oncology, Inc. Common stock. Check Aktis Oncology, Inc. Common stock (AKTS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2024 0.81x $11.90 Million $14.76 Million $2.86 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).